Search research articles
Contact Us
Filters
Showing results (61-70 of 156) with videos related to
Page
of 16
Sort By:
Journal of Clinical Psychopharmacology
|
February 1, 1995
Efficacy trial of the 5-HT2 antagonist MDL 11,939 in patients with generalized anxiety disorder
J J Sramek, R E Robinson, A Suri, et al.
Drug Intelligence & Clinical Pharmacy
|
November 1, 1986
Effect of molindone on weight change in hospitalized schizophrenic patients
M M Parent, S Roy, J Sramek, et al.
Journal of Clinical Psychopharmacology
|
February 1, 1990
An open trial of glycine as an adjunct to neuroleptics in chronic treatment-refractory schizophrenics
J Costa, E Khaled, J Sramek, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1995
The utility of salivary amylase as an evaluation of M3 muscarinic agonist activity in Alzheimer's disease
J J Sramek, N R Cutler, D J Hurley, et al.
Anxiety
|
January 1, 1994
Pilot study of a CCKB antagonist in patients with panic disorder: preliminary findings
J J Sramek, M S Kramer, S A Reines, et al.
The Annals of Pharmacotherapy
|
September 1, 1992
Implications of the study population in the early evaluation of anticholinesterase inhibitors for Alzheimer's disease
N R Cutler, J J Sramek, M F Murphy, et al.
Investigative Ophthalmology & Visual Science
|
November 1, 1988
Ocular renin-angiotensin: immunohistochemical evidence for the presence of prorenin in eye tissue
S J Sramek, I H Wallow, R P Day, et al.
Ophthalmology
|
June 1, 1989
Immunostaining of preretinal membranes for actin, fibronectin, and glial fibrillary acidic protein
S J Sramek, I H Wallow, T S Stevens, et al.
Alzheimer Disease and Associated Disorders
|
January 1, 1995
Orthostasis in Alzheimer disease: a retrospective analysis
S S Jhee, J J Sramek, T S Wardle, et al.
The American Journal of Psychiatry
|
May 1, 1990
Control of bed-wetting with benztropine
J F Costa, J Sramek, R B Bera, et al.
Page
of 16
Search research articles
Search
Showing results (61-70 of 156) with videos related to
Sort By:
Page
of 16
Journal of Clinical Psychopharmacology
|
February 1, 1995
Efficacy trial of the 5-HT2 antagonist MDL 11,939 in patients with generalized anxiety disorder
J J Sramek, R E Robinson, A Suri, et al.
Drug Intelligence & Clinical Pharmacy
|
November 1, 1986
Effect of molindone on weight change in hospitalized schizophrenic patients
M M Parent, S Roy, J Sramek, et al.
Journal of Clinical Psychopharmacology
|
February 1, 1990
An open trial of glycine as an adjunct to neuroleptics in chronic treatment-refractory schizophrenics
J Costa, E Khaled, J Sramek, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1995
The utility of salivary amylase as an evaluation of M3 muscarinic agonist activity in Alzheimer's disease
J J Sramek, N R Cutler, D J Hurley, et al.
Anxiety
|
January 1, 1994
Pilot study of a CCKB antagonist in patients with panic disorder: preliminary findings
J J Sramek, M S Kramer, S A Reines, et al.
The Annals of Pharmacotherapy
|
September 1, 1992
Implications of the study population in the early evaluation of anticholinesterase inhibitors for Alzheimer's disease
N R Cutler, J J Sramek, M F Murphy, et al.
Investigative Ophthalmology & Visual Science
|
November 1, 1988
Ocular renin-angiotensin: immunohistochemical evidence for the presence of prorenin in eye tissue
S J Sramek, I H Wallow, R P Day, et al.
Ophthalmology
|
June 1, 1989
Immunostaining of preretinal membranes for actin, fibronectin, and glial fibrillary acidic protein
S J Sramek, I H Wallow, T S Stevens, et al.
Alzheimer Disease and Associated Disorders
|
January 1, 1995
Orthostasis in Alzheimer disease: a retrospective analysis
S S Jhee, J J Sramek, T S Wardle, et al.
The American Journal of Psychiatry
|
May 1, 1990
Control of bed-wetting with benztropine
J F Costa, J Sramek, R B Bera, et al.
Page
of 16